Warren Averett Asset Management, LLC Crispr Therapeutics Ag Transaction History
Warren Averett Asset Management, LLC
- $8.88 Billion
- Q2 2025
A detailed history of Warren Averett Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Warren Averett Asset Management, LLC holds 15,390 shares of CRSP stock, worth $1.04 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,390
Previous 15,247
0.94%
Holding current value
$1.04 Million
Previous $518,000
44.4%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding CRSP
# of Institutions
532Shares Held
68.7MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$690 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$379 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$249 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$222 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$193 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.28B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....